Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Big_Cheese
    Junior Member
    • Jul 2012
    • 7

    Isoforms in Cufflinks

    Hi,

    I am using cuffdiff and Deseq/edgeR to compare Gene expression levels between mice kidneys between a control and an affected group.

    Both outputs are comparable, the difference is that cufflinks also finds gene isoforms.
    So for example if you compare a random gene you will probably get a 1:1 ratio with the raw read data. But if you look it up in cuffdiff, there are sometimes up to 5 isoforms with very expression ratios. But if you add them together you will get a 1:1 ratio again.
    There are some cases where the isoform seems to "switch".
    So in the control group you have average 5 fpkm for isoform A and 0 for isoform B,
    but in the affected group it's the other way around: isoform B has average 5 fpkm and isoform A has nothing.


    Most of the times when the isoform varies, its with very low FPKM
    example:
    From Gene X,
    isoform A has 40 FPKM in control and 38 in affected
    isoform B has 0 FPKM in control and 0.5 in affected
    isoform C has 5 in control and 2 in affected

    if you add these values, you get the same ratio for Gene X you would get in the raw reads file.

    So my question now is if that means something. Can different isoforms affect the kidneys, or is what I see nothing out of the ordinary and the variations are natural/statistical Errors

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 12:17 PM
0 responses
13 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
37 views
0 reactions
Last Post SEQadmin2  
Working...